[HTML][HTML] In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus

D Zhang, K Wu, X Zhang, S Deng, B Peng - Journal of integrative medicine, 2020 - Elsevier
Objective In this study we execute a rational screen to identify Chinese medical herbs that
are commonly used in treating viral respiratory infections and also contain compounds that …

[HTML][HTML] Traditional Chinese medicine is a resource for drug discovery against 2019 novel coronavirus (SARS-CoV-2)

C Ling - Journal of integrative medicine, 2020 - ncbi.nlm.nih.gov
Novel coronavirus pneumonia, named as COVID-19 by the World Health Organization, has
spread widely since December 2019 [1–3], with more than 40,000 confirmed cases in China …

In Silico Screening of Potential Chinese Herbal Medicine Against COVID-19 by Targeting SARS-CoV-2 3CLpro and Angiotensin Converting Enzyme II Using …

L Gao, J Xu, S Chen - Chinese journal of integrative medicine, 2020 - Springer
Abstract Objective To seek potential Chinese herbal medicine (CHM) for the treatment of
coronavirus disease 2019 (COVID-19) through the molecular docking of the medicine with …

[HTML][HTML] Potential treatment of COVID-19 with traditional Chinese medicine: what herbs can help win the battle with SARS-CoV-2?

L Li, Y Wu, J Wang, H Yan, J Lu, Y Wang, B Zhang… - Engineering, 2022 - Elsevier
Traditional Chinese medicine (TCM) has been successfully applied worldwide in the
treatment of coronavirus disease 2019 (COVID-19), which is caused by severe acute …

[HTML][HTML] In-silico evaluation of bioactive compounds from tea as potential SARS-CoV-2 nonstructural protein 16 inhibitors

R Singh, VK Bhardwaj, J Sharma, R Purohit… - Journal of traditional and …, 2022 - Elsevier
Background and aim A novel coronavirus, called the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has been found to cause COVID-19 in humans and some …

[HTML][HTML] In silico screening of potential anti–COVID-19 bioactive natural constituents from food sources by molecular docking

J Xu, L Gao, H Liang, S Chen - Nutrition, 2021 - Elsevier
Objective Through molecular docking of Severe Acute Respiratory Syndrome Coronavirus 2
(SARS-CoV-2) 3CL hydrolytic enzyme (3CL pro) and angiotensin-converting enzyme Ⅱ …

Network pharmacology and molecular docking analysis on molecular targets and mechanisms of Huashi Baidu formula in the treatment of COVID-19

Q Tao, J Du, X Li, J Zeng, B Tan, J Xu… - Drug development and …, 2020 - Taylor & Francis
Abstract Purpose Huashi Baidu formula (HSBDF) was developed to treat the patients with
severe COVID-19 in China. The purpose of this study was to explore its active compounds …

Systems pharmacology-based drug discovery and active mechanism of natural products for coronavirus pneumonia (COVID-19): An example using flavonoids

B Wang, Y Ding, P Zhao, W Li, M Li, J Zhu… - Computers in Biology and …, 2022 - Elsevier
Background Recently, the value of natural products has been extensively considered
because these resources can potentially be applied to prevent and treat coronavirus …

Evaluation of certain medicinal plants compounds as new potential inhibitors of novel corona virus (COVID-19) using molecular docking analysis

AA Alrasheid, MY Babiker, TA Awad - In silico pharmacology, 2021 - Springer
SARS-CoV-2 is a new strain of coronavirus that appeared in China in December 2019, in
recent years, great progress has been made in developing new antiviral drugs, and natural …

High throughput virtual screening reveals SARS-CoV-2 multi-target binding natural compounds to lead instant therapy for COVID-19 treatment

B Naik, N Gupta, R Ojha, S Singh, VK Prajapati… - International Journal of …, 2020 - Elsevier
The present-day world is severely suffering from the recently emerged SARS-CoV-2. The
lack of prescribed drugs for the deadly virus has stressed the likely need to identify novel …